What is Atomo?
Atomo leverages sophisticated machine learning and advanced analytics to pinpoint individuals and patient populations exhibiting the most significant unmet medical needs for specific diseases. With a deep-rooted expertise spanning three decades in Healthcare, Life Sciences, and Health Economics and Outcomes Research (HEOR), Atomo's core competency lies in its innovative approach to integrating disparate datasets. This enables the precise identification of patients with critical needs and the discovery of optimal strategies to address these challenges, positioning Atomo as a key player in data-driven healthcare solutions.
How much funding has Atomo raised?
Atomo has raised a total of $2.6M across 1 funding round:
Angel/Seed
$2.6M
Angel/Seed (2019): $2.6M, investors not publicly disclosed
What's next for Atomo?
The substantial enterprise-level funding indicates Atomo is entering a critical growth phase, likely focusing on expanding its technological infrastructure, enhancing its data analytics capabilities, and broadening its market reach. Strategic partnerships and further development of its AI-driven patient identification platform are anticipated. This capital infusion will likely accelerate Atomo's mission to optimize healthcare delivery by ensuring resources are directed towards those with the greatest need, potentially leading to significant advancements in patient outcomes and healthcare efficiency.
See full Atomo company page
